Similar companies
Income Statement (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 3.56B | 1% |
| Gross Profit | 1.03B | 2% |
| Cost of Revenue | 2.54B | 2.3% |
| Operating expense | 629M | 3.6% |
| Net Income | 261M | 9.8% |
| EBITDA | 564M | 6% |
Balance Sheet (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 18.3B | 1.1% |
| Total Liabilities | 9.55B | 0.2% |
| Total Equity | 8.7B | 2.6% |
| Shares Outstanding | 84M | 0.5% |
Cash Flow (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | 387M | 37.6% |
| Cash from investing | -374M | 297.4% |
| Cash from financing | -60M | 77.7% |
EPS
Financial Highlights for LabCorp in Q3 '25
LabCorp reported a revenue of 3.56B, which is a 1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 1.03B, marking a -2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 2.54B, a 2.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 629M, showing a -3.6% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 261M, showing a 9.8% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 564M, showing a 6% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
LabCorp faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.
